Chim Lang

+44 (0)1382 383013
Head of Division - Molecular & Clinical Medicine & Professor of Cardiology

Bio

Teaching

Full contribution to teaching in Dundee, especially cardiology and clinical pharmacology. Member of Undergraduate Medical School Assessment Committee. External undergraduate examinerships (National University of Singapore, University of Malaya, International Medical University, Malaysia, National University of Malaysia). Supervisor of 25 MD/PhDs personally. External examiner for MD (Universities of Birmingham, Cardiff, Edinburgh, Glasgow)

Biography

Professor Lang is a consultant cardiologist and clinical pharmacologist and Professor of Cardiology at Ninewells Hospital and Medical School, Dundee, United Kingdom. He trained in both cardiology and clinical pharmacology in the United Kingdom and in the United States where he was a Merck International Fellow in Clinical Pharmacology at Vanderbilt University, Nashville and a Fulbright Scholar at Columbia University, New York. He is a Fellow of the Royal Colleges of Physicians of London and Edinburgh and the American College of Cardiology.

Research

His research takes a multi-disciplinary approach to the understanding of the pathophysiology and pharmacogenetics of cardiovascular diseases and to the development of treatment strategies in patients with cardiovascular diseases. He leads an integrated cardiovascular research laboratory dedicated and equipped to the study of cardiac and vasomotor regulation. These techniques are applied towards translational research and in the development of biomarkers and novel treatment strategies in patients with cardiovascular diseases. Prof Lang is the Work Package Lead for the validation cohort for the FP-7 funded BIOSTAT-CHF study that aims optimize the treatment of heart failure for each individual using information from genomics and proteomics. A wide range of funding bodies including the British Heart Foundation, MRC, Chief Scientist Office, Chest Heart and Stroke Scotland, Tenovus and the European commission Seventh Framework Programme (FP-7) funds his research. 

Publications

Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failure
1/2019, European Journal of Heart Failure
Research Output: Contribution To Journal > Article

Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes : A systematic review and meta-analysis
1/2019, Heart
Research Output: Contribution To Journal > Article

Differential Association of Genetic Risk of Coronary Artery Disease with development of Heart Failure with Reduced Versus Preserved Ejection Fraction : A GoDARTS Mendelian Randomization Study and Meta-Analysis
11/2018, Circulation
Research Output: Contribution To Journal > Letter

Clinical correlates and outcome associated with changes in 6-Minute Walking Distance in Patients with Heart Failure : findings from the BIOSTAT-CHF study
11/2018, European Journal of Heart Failure
Research Output: Contribution To Journal > Article

Prognostic Significance of Changes in Heart Rate Following Uptitration of Beta-Blockers in Patients with Sub-Optimally Treated Heart Failure with Reduced Ejection Fraction in Sinus Rhythm versus Atrial Fibrillation
12/2018, Clinical Research in Cardiology
Research Output: Contribution To Journal > Article

Novel Endotypes in Heart Failure : Effects on Guideline-Directed Medical Therapy
10/2018, European Heart Journal
Research Output: Contribution To Journal > Article

Effects of the coronary artery disease associated LPA and 9p21 loci on risk of aortic valve stenosis
11/2018, International journal of cardiology
Research Output: Contribution To Journal > Article

Non-cardiac Comorbidities in Heart Failure with Reduced, Mid-range and Preserved Ejection Fraction
4/2018, International journal of cardiology
Research Output: Contribution To Journal > Article

Comparing biomarker profiles of patients with heart failure : atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction
7/2018, European Heart Journal
Research Output: Contribution To Journal > Article

Potential mechanisms for the effects of far-infrared on the cardiovascular system : a review
8/2018, VASA
Research Output: Contribution To Journal > Review article

View full profile on research portal

Press



Diabetes drug could help reduce cardiovascular disease

Chim Lang

22/08/16

1 media contribution

Press/Media: Research



BBC News. Type 2 diabetes drug 'could treat other conditions'

Chim Lang

19/08/16

1 media contribution

Press/Media: Research



Type 2 diabetes drug 'could treat other conditions'

Chim Lang

19/08/16

1 item of media coverage

Press/Media: Research



'Super-dose statins can add years to our lives,' says doctors

Chim Lang

21/02/14

1 item of media coverage

Press/Media: Research



'Super-dose statins can add years to our lives

Chim Lang

21/02/14

1 item of media coverage

Press/Media: Research



High Dose Allopurinol Reduces Left Ventricular Mass In Patients With Ischemic heart Disease

Sushma Rekhraj, Stephen J. Gandy, Benjamin Szwejkowski, Adnan Nadir, Awsan Noman, Graeme Houston, Chim Lang, Jacob George & Allan Struthers

5/03/13

1 item of media coverage

Press/Media: Research



Blood tests pick up early 'silent' heart disease

Adnan Nadir, Sushma Rekhraj, Li Wei, Tiong Lim, John Davidson, Thomas MacDonald, Chim Lang, Eleanor Dow & Allan Struthers

24/09/12

1 item of media coverage

Press/Media: Research



Diabetes drug may help heart patients

Chim Lang

3/07/12

1 item of media coverage

Press/Media: Research



Diabetic drug may offer benefits in heart failure

Chim Lang & Graham Rena

2/07/12

1 item of media coverage

Press/Media: Research



ACE, ARB May Benefit Aortic Regurgitation

Chim Lang

31/10/11

1 item of media coverage

Press/Media: Research



View full profile on research portal

Activities

‘Blood pressure and heart failure: Some of the complexities of a love hate relationship.

Chim Lang (Speaker)
1 Sep 2014

Activity: Talk or presentation typesInvited talk

Activity Type: Talk

“Diabetes and Heart failure: Update on research and treatment’

Chim Lang (Speaker)
1 Aug 2014

Activity: Talk or presentation typesInvited talk

Activity Type: Talk

Diabetes UK Professional Conference 2013

Chim C. Lang (Participant)
13 Mar 201315 Mar 2013

Activity: Participating in or organising an event typesParticipation in conference

Activity Type: Attendance

‘Off Target Cardiovascular Effects of Diabetic Therapies’.

Chim Lang (Speaker)
1 Oct 2012

Activity: Talk or presentation typesInvited talk

Activity Type: Talk

Diabetic heart disease

Chim Lang (Speaker)
1 Mar 2009

Activity: Talk or presentation typesInvited talk

Activity Type: Talk

Targeting the heart rate in heart failure’

Chim Lang (Speaker)
3 Nov 2007

Activity: Talk or presentation typesInvited talk

Activity Type: Talk

46. ‘How to Set Up the Exercise Training in CHF?

Chim Lang (Speaker)
27 Oct 200630 Oct 2006

Activity: Talk or presentation typesInvited talk

Activity Type: Talk

Adoption of the Update ESC and ACC/AHA Guidelines in Asian Countries’

Chim Lang (Speaker)
27 Oct 200630 Oct 2006

Activity: Talk or presentation typesInvited talk

Activity Type: Talk

How much responsibility should heart failure nurses take?

Chim Lang (Speaker)
27 Oct 200630 Oct 2006

Activity: Talk or presentation typesInvited talk

Activity Type: Talk

50. ‘End points in heart failure: Is there a role for cardiopulmonary exercise testing?’.

Chim Lang (Speaker)
1 Sep 2006

Activity: Talk or presentation typesInvited talk

Activity Type: Talk

View full profile on research portal